Trajan Group Holdings (ASX: TRJ) is an Australian-listed company in the Healthcare sector with a market capitalisation of $49.7M and the 1022nd-largest security on the ASX by market capitalisation. The TRJ share price is $0.325, up 10.17% today and down 56.34% over the past 12 months. Shares have traded between $0.265 and $0.97 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), Trajan Group Holdings reported revenue of $84.1M and a net loss of $449,000.
About Trajan Group Holdings Limited
Headquartered in Ringwood, Australia, and established in 2011, Trajan Group Holdings Limited is a global enterprise focused on designing, manufacturing, marketing, and distributing a diverse range of analytical and life science instruments and associated products. Its extensive operations cover Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India. The company's activities are organized into two main divisions: Analytical Products and Life Science Solutions. The Analytical Products segment provides essential components such as syringes, GC consumables, septa, caps, liners, gas filters, and tubing. It also supplies pathology and sampling equipment, along with automated systems tailored for examining biological, food, and environmental samples. Complementing this, Trajan delivers nutrition testing solutions for various clients, including pathology laboratories, research and clinical trial initiatives, personalized nutrition programs, corporate wellness strategies, and health insurance providers. The company's offerings further extend to automation workflow solutions, micro-sampling devices, and comprehensive data analysis services.
